Skip to main content
. Author manuscript; available in PMC: 2013 Aug 15.
Published in final edited form as: Clin Cancer Res. 2012 Jun 6;18(14):3731–3736. doi: 10.1158/1078-0432.CCR-11-2859

Table 2.

Weibull mixture cure model regression results

Estimate (95% CI) P
Long-term survivor model (OR)
  TT1 (ref.)
  TT2 4.75 (2.22–10.18) 0.036
  TT2+ 2.36 (1.06–5.26) <0.001
  TT3 20.23 (9.11–44.90) <0.001
  Age 0.97 (0.95–0.97) 0.018
  Cytogenetic abnormalities 0.42 (0.25–0.70) 0.001
Short-term survival model (HR)
  TT1 (ref.)
  TT2 0.77 (0.59–1.00) 0.052
  TT2+ 0.66 (0.48–0.93) 0.017
  TT3 0.92 (0.52–1.64) 0.78
  Age 1.00 (0.999–1.02) 0.25
Cytogenetic abnormalities 1.41 (1.15–1.73) 0.001